This review summarizes recent progress and developments as well as the most important pitfalls in targeted alpha-particle therapy, covering single alpha-particle emitters as well as in vivo alpha-particle generators. It discusses the production of radionuclides like 211At, 223Ra, 225Ac/213Bi, labelling and delivery employing various targeting vectors (small molecules, chelators for alpha-emitting nuclides and their biomolecular targets as well as nanocarriers), general radiopharmaceutical issues, preclinical studies, and clinical trials including the possibilities of therapy prognosis and follow-up imaging. Special attention is given to the nuclear recoil effect and its impacts on the possible use of alpha emitters for cancer treatment, proper dose estimation, and labelling chemistry. The most recent and important achievements in the development of alpha emitters carrying vectors for preclinical and clinical use are highlighted along with an outlook for future developments.
- MeSH
- Actinium chemistry therapeutic use MeSH
- Alpha Particles therapeutic use MeSH
- Astatine chemistry therapeutic use MeSH
- Bismuth chemistry therapeutic use MeSH
- Chelating Agents chemistry pharmacokinetics MeSH
- Radiation Dosage MeSH
- Heterocyclic Compounds, 1-Ring chemistry pharmacokinetics MeSH
- Heterocyclic Compounds chemistry pharmacokinetics MeSH
- Small Molecule Libraries chemistry pharmacokinetics MeSH
- Humans MeSH
- Neoplasms pathology radiotherapy MeSH
- Drug Carriers administration & dosage chemistry MeSH
- Radiopharmaceuticals chemistry therapeutic use MeSH
- Radioisotopes chemistry therapeutic use MeSH
- Radium chemistry therapeutic use MeSH
- Dose-Response Relationship, Radiation MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Targeted alpha therapy with radionuclides undergoing multiple alpha-particle decays is a promising method of nuclear medicine. To study the effectiveness of alpha versus beta emitters, survival of DU145 prostate cancer cells exposed to 223Ra or 177Lu was assessed. Per decay, the cells were much more sensitive to the alpha than beta emitter. However, per unit dose the sensitivities would be comparable, contrary to the well-known evidence, if the decay energy were deposited within the sample completely and homogeneously. Measurements by Timepix detectors showed about three times higher counts of alpha particles above than below the sample. After the first alpha decay of 223Ra to 219Rn, this gas likely moves upwards and its subsequent three alpha decays occur in the upper part of the sample. Correct estimation of absorbed dose is a critical issue when analysing in vitro data and when translating their results to clinical applications.
- MeSH
- Alpha Particles therapeutic use MeSH
- Humans MeSH
- Radiometry methods MeSH
- Radioisotopes therapeutic use MeSH
- Radium * MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
Hepatology, ISSN 0270-9139 Supplement Vol. 26. 3
155S s. : il. ; 30 cm
- MeSH
- Hepatitis C epidemiology therapy diagnosis MeSH
- Interferon-alpha therapeutic use MeSH
- Hepatitis B virus MeSH
- Publication type
- Collected Work MeSH
- Conspectus
- Patologie. Klinická medicína
- NML Fields
- gastroenterologie
- infekční lékařství
The importance of fluorescence light microscopy for understanding cellular and sub-cellular structures and functions is undeniable. However, the resolution is limited by light diffraction (~200-250 nm laterally, ~500-700 nm axially). Meanwhile, super-resolution microscopy, such as structured illumination microscopy (SIM), is being applied more and more to overcome this restriction. Instead, super-resolution by stimulated emission depletion (STED) microscopy achieving a resolution of ~50 nm laterally and ~130 nm axially has not yet frequently been applied in plant cell research due to the required specific sample preparation and stable dye staining. Single-molecule localization microscopy (SMLM) including photoactivated localization microscopy (PALM) has not yet been widely used, although this nanoscopic technique allows even the detection of single molecules. In this study, we compared protein imaging within metaphase chromosomes of barley via conventional wide-field and confocal microscopy, and the sub-diffraction methods SIM, STED, and SMLM. The chromosomes were labeled by DAPI (4',6-diamidino-2-phenylindol), a DNA-specific dye, and with antibodies against topoisomerase IIα (Topo II), a protein important for correct chromatin condensation. Compared to the diffraction-limited methods, the combination of the three different super-resolution imaging techniques delivered tremendous additional insights into the plant chromosome architecture through the achieved increased resolution.
- MeSH
- Chromosomes, Plant chemistry genetics metabolism MeSH
- DNA Topoisomerases, Type II metabolism MeSH
- Fluorescent Dyes chemistry MeSH
- Microscopy, Fluorescence methods MeSH
- Indoles chemistry MeSH
- Hordeum cytology genetics MeSH
- Microscopy, Confocal methods MeSH
- Metaphase genetics MeSH
- Reproducibility of Results MeSH
- Single Molecule Imaging methods MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
- MeSH
- Adult MeSH
- Hepatitis B blood pathology therapy MeSH
- Interferon-alpha therapeutic use MeSH
- Middle Aged MeSH
- Humans MeSH
- Mutation MeSH
- Hepatitis B virus genetics drug effects MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Case Reports MeSH
Závěrečná zpráva o řešení grantu Interní grantové agentury MZ ČR
Přeruš. str. : tab., grafy ; 32 cm
Optimalizace terapie interferonem alfa ("tailoring"terapie) u chronických hepatitid B a C pomocí monitorování virémie a stanovení sérotypu viru hepatitidy C.; Optimalization of interferon alpha therapy ("tailoring"therapy) in patients with chronic hepatitis B and C using monitoring viremia and detection of hepatitis C virus serotype.
- MeSH
- Hepatitis B, Chronic drug therapy MeSH
- Hepatitis C, Chronic drug therapy MeSH
- Interferon-alpha therapeutic use MeSH
- Ribavirin therapeutic use MeSH
- Hepatitis B virus drug effects drug effects MeSH
- Treatment Outcome MeSH
- Conspectus
- Patologie. Klinická medicína
- NML Fields
- virologie
- infekční lékařství
- NML Publication type
- závěrečné zprávy o řešení grantu IGA MZ ČR
Bacteriophages are ubiquitous in nature and represent a vast repository of genetic diversity, which is driven by the endless coevolution cycle with a diversified group of bacterial hosts. Studying phage-host interactions is important to gain novel insights into their dynamic adaptation. In this study, we isolated 12 phages infecting species of the Acinetobacter baumannii-Acinetobacter calcoaceticus complex which exhibited a narrow host range and similar morphological features (podoviruses with short tails of 9-12 nm and isometric heads of 50-60 nm). Notably, the alignment of the newly sequenced phage genomes (40-41 kb of DNA length) and all Acinetobacter podoviruses deposited in Genbank has shown high synteny, regardless of the date and source of isolation that spans from America to Europe and Asia. Interestingly, the C-terminal pectate lyase domain of these phage tail fibres is often the only difference found among these viral genomes, demonstrating a very specific genomic variation during the course of their evolution. We proved that the pectate lyase domain is responsible for phage depolymerase activity and binding to specific Acinetobacter bacterial capsules. We discuss how this mechanism of phage-host co-evolution impacts the tail specificity apparatus of Acinetobacter podoviruses.
- MeSH
- Acinetobacter baumannii virology MeSH
- Acinetobacter calcoaceticus virology MeSH
- Genome, Viral genetics MeSH
- Host Specificity physiology MeSH
- Podoviridae classification genetics metabolism MeSH
- Polygalacturonase metabolism MeSH
- Polysaccharide-Lyases metabolism MeSH
- Protein Domains physiology MeSH
- Base Sequence MeSH
- Virion genetics MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Asia MeSH
- Europe MeSH
- MeSH
- DNA, Viral analysis MeSH
- Adult MeSH
- Interferon-alpha therapeutic use MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Hepatitis, Viral, Human drug therapy blood MeSH
- Hepatitis B virus isolation & purification MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH